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1. Introduction 
Distamycin A, an antibiotic substance produced 
by Streptomyces distallicus, is endowed with cyto- 
static properties evidenced by its activity on some 
experimental tumors of the mouse and the rat [l] . It 
suppresses the multiplication of T, and T, phages in 
E. coli K12 [2] and interferes with the multiplication 
of some DNA-viruses such as vaccinia, herpes simplex 
and adenoviruses [3] , Another interesting feature of 
distamycin A is its ability to prevent the induction of 
bacterial adaptive enzymes of E. coli [4,5]. 
In some recent publications [6,7] we have reported 
the reaction of this antibiotic on the structure and 
template activity of DNA. The absorbance of DNA 
decreases in the presence of distamycin A. This effect 
is dependent on the antibiotic/DNA-P ratio (r). The 
melting profile of native DNA shifts towards higher 
temperatures with increasing antibiotic concentration. 
The hyperchromicity also increases from 40 to about 
60% in the presence of distamycin when r is raised 
from r=O to r=l [6]. These interactions lead to a pro- 
nounced inhibition of the incorporation of AMP into 
RNA in the DNA-directed RNA-polymerase system. 
The structure of this antibiotic also obtained by 
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total synthesis [8] , is characterized by 3 residues of 
l-methyl-4-aminopyrrole-2carboxylic acid and 2 side 
chains, the first constituted by a formyl group, and the 
second by a propionamidine chain (fig. 1, compound 
I). Arcamone et al. [9, lo] have recently succeeded 
in synthesizing some structural analogues of distamycin 
A. These structural modifications were obtained by 
substitution of the formyl group (fig. 1, R,), substi- 
tution of the propionamidine side chain (fig. 1, Rz) 
and variation of the number of pyrrole residues. The 
cytotoxicity , antiviral activity and the inhibition of 
DNA-dependent RNA synthesis by distamycin deriva- 
tives containing 2, 3,4 and 5 pyrrole rings has been 
recently studied by Chandra et al. [ 1 l] . They found 
that the antiviral activity of distamycins and their 
action on the template activity of DNA are dependent 
on the number of pyrrole rings in the molecule. The 
present communication describes the activity of dist- 
amycin derivatives with a constant number of pyrrole 
rings, but with various substitutions at the side chains 
(fig. l), in various biological systems, and on the 
DNA-dependent RNA polymerase reaction. 
2. Materials and methods 
14C- or 3H-ATP was obtained as tetralithium salt 
from NEN Chemical GmbH, Germany; other triphos- 
phates were obtained from Zellstofffabrik Waldhof, 
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Chemical structures of distamycin derivatives. 
Mannheim. Calf thymus DNA was supplied by Serva 
and Co., Heidelberg. All other chemicals were analytical 
grade reagents from Merck, Darmstadt. 
2.1. RNA-polymerase reaction 
RNA polymerase was isolated from E. coli K12 
cells according to the procedure by Burgess [ 121 and 
kept in buffer containing 50% glycerol at -20”. The 
reaction mixture contained, in 0.25 ml, 0.04 M Tris, 
pH 7.9,O.Ol M MgCl, , 0.1 mM EDTA, 0.1 mM 
dithiothreitol, 0.15 M KCl, 0.15 mM UTP, CTP and 
GTP, 0.15 mM 3H-ATP and 0.15 mg per ml of calf 
thymus DNA. The reaction was started with about 10 
pg enzyme protein and incubations were carried out 
for 20 min at 37”. The reaction was stopped by adding 
3 ml of 5% trichloroacetic acid (TCA) and serum 
albumin was used as carrier. The precipitate was col- 
lected on a membrane filter (Sartorius, Gdttingen, SM 
11306) and washed 4 times with 3 ml of 2% TCA. The 
filter was dried and counted with toluol scintillation 
fluid in a Packard liquid scintillation spectrometer. 
Protein was estimated by the method of Lowry et al. 
[131- 
2.2. Cytotoxicity assay 
The cytotoxicity of distamycin derivatives was 
estimated on the basis of the morphological modifica- 
tions induced in HeLa cell cultures, after incubation 
for 40 hr in Hanks’ saline solution +0.5% lactalbumin 
hydrolysate t5% calf serum (HLS). The percent in- 
hibition of cellular growth was evaluated according to 
Morasca [ 141. 
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2.3. Assay on vaccina virus 
Cultures of HeLa cells (grown in HLS medium) or 
mouse-embryo cells (grown in HLS medium containing 
0.1% yeastolate) infected with vaccinia virus (Strain 
WR/ATCC) were used. Preliminary assays were made 
according to Herrmann et al. 1151. Subsequent studies 
were carried out by assessing the inhibition of plaque 
formation (ECP) as well as the inhibition of infectious 
virus production in test tube cultures treated with the 
compounds for 40 hr after the absorption of the virus. 
3. Results and discussion 
The cytotoxicity and antiviral activity of distamycin 
derivatives, obtained by substitutions of the formyl 
group (II) or the propionamidine chain (III and IV), 
is shown in table 1. Substitution of the formyl group 
with a cyclopentyl propionyl chain does not influence 
its cytotoxicity but the compound loses its antiviral 
activity completely. The substitution of the propion- 
amidine group with a benzamidine moiety doubles 
the cytotoxicity of the compound. The antiviral 
activity of this compound is, however, only 44% of 
that of distamycin A. The analogue containing butyr- 
amidine group in place of the propionamidine moiety 
(IV) also exhibits a higher cytotoxicity than the com- 
pound I. This has only 3 1% of the antiviral activity of 
compound I. 
These results allow the conclusion that the presence 
of the formyl group in distamycin is necessary for its 
antiviral activity. Studies with other derivatives, where 
the formyl group was substituted by a nitro, amino or 
acetyl group have shown that all these derivatives are 
completely inactive against viruses. However, substi- 
tutions at the formyl group do not influence the cyto- 
toxicity of the compound. Compounds having substi- 
tutions at the propionamidine are active against 
viruses but exhibit a much higher toxicity. An inter- 
esting compound of this group is the acetamidine 
derivative which showed a higher antiviral activity 
(150%) than distamycin A. 
Using the melting behaviour of DNA-antibiotic 
complexes as a criterion of binding, a drastic increase 
in the melting temperature of DNA was observed in 
the presence of distamycin [6] . This interaction leads 
to a concentration-dependent inhibition of DNA- 
dependent RNA-polymerase reaction. Table 2 shows 
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Table 1 Table 2 
Cytotoxicity and antiviral activity of the distamycin derivatives. Distamycin A inhibition of DNAdependent RNA polymerase 
reaction. 
Compound 
tested Cytotoxicity* 
Inhibition of vaccinia 
virus multiplication. 
Inhibition (%)* 
1 100** 100** 
II 100 0 
III 200 44 
IV 150 31 
_____-- 
* Activity calculated with respect to that of compound I 
(Distamycin A) considered = 100. 
** Absolute values (IDsc pg/ml): Cytotoxicity = 80; WR=2. 
the template activity of calf thymus DNA in the 
presence of the natural antibiotic (distamycin A). In 
these experiments compound I (distamycin A) was 
pipetted into reaction mixtures containing DNA, 
buffer and the triphosphates. The reaction was started 
with DNA-dependent RNA-polymerase. Under these 
conditions we observed in the range 1 X 1 O- -8 X 
10m5 M a concentration-dependent inhibition of RNA- 
polymerase reaction. As follows from table 2, more 
than 80% of the reaction is inhibited at 8 X lo-’ M 
concentration of distamycin A. 
Chandra et al. [ 1 l] have recently shown that the 
antiviral activity of distamycins and their action on 
the template activity of DNA are dependent on the 
number of pyrrole rings in the molecule. The distamycin 
derivative with 5 pyrrole rings (Dist/5) has 10 times 
higher antiviral activity than distamycin A (with 3 
pyrrole rings), and is a better inhibitor of the RNA- 
polymerase reaction. It was therefore interesting to 
study the correlation between the antiviral activity 
and the inhibition of RNA-polymerase reaction by 
compounds 1, II, III and IV. The effect of an equi- 
molar concentration (8 X lo-’ M) of the distamycin 
derivatives on the template activity of DNA is shown 
in table 3. The derivatives were added into the reaction 
mixture as described above. The highest inhibition was 
obtained with the natural antibiotic (distamycin A) 
followed by compounds IV, II and III, respectively. 
The cyclopentyl-propionyl derivative, having no anti- 
viral activity is still able to inhibit the RNA-polymerase 
reaction to more than 50%. This indicates that factors, 
other than its binding to DNA, are responsible for its 
inactivity against viruses. One of the many possibilities 
for this result may be the permeability of this com- 
AMP-3H 
System Incorporation 
(cpm/reaction 
mixture) 
Incorporation 
(%) 
Complete 3843 100 
Without DNA 114 2.9 
Complete + Compound I 
(Distamycin-A) 
4 X lo-’ M 1064 28 
8 X lo-’ M 718 19 
- ___- 
Distamycin A was pipetted into reaction mixture containing 
calf thymus DNA, buffer and the triphosphates. The reaction 
was started with DNA-dependent RNA-polymerase. For details 
see Materials and methods. 
Table 3 
Inhibition of DNA-dependent RNA polymerase reaction by 
distamycin derivatives. 
AMP-3H 
Compound added* 
Incorporation 
(cpm/reaction 
mixture) 
Incorporation 
(%) 
None 3801 too 
I 650 17 
II 1792 47 
III 1990 53 
IV 980 26 
* Concentration = 8 X lo-’ M. 
pound towards the host cell. The inhibition of RNA- 
polymerase reaction by compounds III and IV is in good 
correlation to their antiviral activity, compared to 
distamycin A. Our preliminary results on the melting 
behaviour of DNA in the presence of these derivatives 
are in good agreement with the present data. These 
studies will be reported later. 
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